My Watchlist Items

      No Watchlist
Exagen Inc. (XGN)
   5.272   0.05200005(+0.9961695%)
TitleNamePayCurrency PayGenderYear BornTitle Since
Senior Vice President of Sales and Marketing Mr. John Wegener N/A USD male N/A N/A
Chief Scientific Officer Dr. Anja Kammesheidt Ph.D. N/A USD N/A N/A
Chief Technology Officer Dr. Ming-Chou Lee Ph.D. N/A USD N/A N/A
Chief Operating Officer Mr. Mark Hazeltine N/A USD male N/A N/A
Chief Medical Officer Dr. Debra Jeske Zack 576660 USD 1957 N/A
Chief Financial Officer & Corporation Sec. Mr. Kamal Adawi M.S., MBA 620300 USD male 1979 N/A
Chief Executive Officer, Pres & Director Mr. Fortunato Rocca 1080000 USD male 1961 N/A
SymbolDateRatingRating Score Rating Details
XGN 11 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
XGN 9 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
XGN 8 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
XGN 5 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
XGN 4 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
XGN 3 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 2 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 1 August, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 29 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 28 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 27 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 26 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 25 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 22 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 21 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 20 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 19 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 18 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 15 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 14 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 13 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 12 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 11 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 8 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 7 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 6 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 5 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 1 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 30 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 29 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 28 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 27 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 24 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 23 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 22 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 21 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 17 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 16 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 15 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 14 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 13 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 10 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 9 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 8 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 7 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 6 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 3 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 2 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 1 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 31 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 27 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 26 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 25 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 24 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 23 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 20 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 19 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 18 May, 2022 A- 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 17 May, 2022 A- 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 16 May, 2022 A- 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 13 May, 2022 A- 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 12 May, 2022 A- 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 11 May, 2022 A- 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Buy)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 10 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 9 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 6 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 5 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 4 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 3 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 29 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 28 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 27 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 26 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 25 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 22 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 21 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 20 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 19 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 18 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 15 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 14 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 13 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 12 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 11 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 8 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 7 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 6 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 5 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 4 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 1 April, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 31 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 30 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 29 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 28 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 25 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 24 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 23 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 22 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 21 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
XGN 18 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
CAPITAL ADVISORS, LTD. LLC 161 30 June, 2022 161
JPMORGAN CHASE & CO 7871 30 June, 2022 -1023
PLATINUM INVESTMENT MANAGEMENT LTD 400000 30 June, 2022 0
TRUIST FINANCIAL CORP 11740 30 June, 2022 -221
PARALLEL ADVISORS, LLC 4213 30 June, 2022 0
NEW YORK STATE COMMON RETIREMENT FUND 97 30 June, 2022 -6800
FIRST HORIZON ADVISORS, INC. 1293 30 June, 2022 798
UBS GROUP AG 131669 30 June, 2022 -298
FIRST BANK & TRUST 23176 30 June, 2022 7423
BRINKER CAPITAL INVESTMENTS, LLC 90596 30 June, 2022 -2622
ADVISOR GROUP HOLDINGS, INC. 5256 30 June, 2022 302
PARADIGM CAPITAL MANAGEMENT INC/NY 81189 30 June, 2022 24289
HIGHTOWER TRUST SERVICES, LTA 2683578 30 June, 2022 2683578
PERKINS CAPITAL MANAGEMENT INC 236975 30 June, 2022 36000
COWEN AND COMPANY, LLC 1355414 30 June, 2022 -29217
PENBROOK MANAGEMENT LLC 88100 30 June, 2022 -500
COWEN PRIME ADVISORS LLC 500 30 June, 2022 -98900
DEUTSCHE BANK AG\ 73344 30 June, 2022 -5609
ENVESTNET ASSET MANAGEMENT INC 26128 30 June, 2022 397
RUSSELL INVESTMENTS GROUP, LTD. 3439 30 June, 2022 0
CITIGROUP INC 92 30 June, 2022 -834
COOPER CREEK PARTNERS MANAGEMENT LLC 153468 31 March, 2022 153468
NUVEEN ASSET MANAGEMENT, LLC 17388 31 March, 2022 0
ROYAL BANK OF CANADA 785 31 March, 2022 -1423
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 27074 31 March, 2022 0
MORGAN STANLEY 534571 31 March, 2022 10479
BLACKROCK INC. 571313 31 March, 2022 -12828
TOWER RESEARCH CAPITAL LLC (TRC) 1929 31 March, 2022 962
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 3627 31 March, 2022 -2161
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75000 31 March, 2022 -12000
PLATINUM INVESTMENT MANAGEMENT LTD 400000 31 March, 2022 0
SILVERCREST ASSET MANAGEMENT GROUP LLC 517617 31 March, 2022 4727
AMERITAS INVESTMENT PARTNERS, INC. 849 31 March, 2022 0
STATE STREET CORP 132023 31 March, 2022 4579
WELLS FARGO & COMPANY/MN 4088 31 March, 2022 -3595
BARCLAYS PLC 7066 31 March, 2022 7066
GEODE CAPITAL MANAGEMENT, LLC 153500 31 March, 2022 2676
NATIXIS 125000 31 March, 2022 0
STONEPINE CAPITAL MANAGEMENT, LLC 1121040 31 March, 2022 262473
AMALGAMATED FINANCIAL CORP. 1395 31 March, 2022 1395
LEGAL & GENERAL GROUP PLC 907 31 March, 2022 0
BANK OF NEW YORK MELLON CORP 25917 31 March, 2022 -474
NANTAHALA CAPITAL MANAGEMENT, LLC 159253 31 March, 2022 -27683
AMERICAN INTERNATIONAL GROUP, INC. 5125 31 March, 2022 -361
ADVISORS CAPITAL MANAGEMENT, LLC 39769 31 March, 2022 2251
BANK OF AMERICA CORP /DE/ 12048 31 March, 2022 -4365
NORTHERN TRUST CORP 85110 31 March, 2022 -4443
AMALGAMATED BANK 1395 31 March, 2022 1395
VANGUARD GROUP INC 537137 31 March, 2022 -2960
PARADIGM CAPITAL MANAGEMENT INC/NY 56900 31 March, 2022 15234
FMR LLC 126 31 March, 2022 126
DIMENSIONAL FUND ADVISORS LP 72051 31 March, 2022 24038
WASATCH ADVISORS INC 1089312 31 March, 2022 -16448
RTW INVESTMENTS, LP 990143 31 March, 2022 168729
CAPTRUST FINANCIAL ADVISORS 340 31 March, 2022 0
HolderSharesDate ReportedWeight Percent
NEW YORK STATE COMMON RETIREMENT FUND 97 30 June, 2022 N/A
DIMENSIONAL FUND ADVISORS LP 72051 31 March, 2022 N/A
iShares Russell 2000 ETF 101110 31 August, 2020 N/A
iShares Micro-Cap ETF 12137 31 August, 2020 0.02
Vanguard Total Stock Market Index Fund 207653 31 August, 2020 N/A
iShares Russell 2000 Growth ETF 43930 31 August, 2020 0.01
Schwab Small-Cap Index Fund 10253 31 July, 2020 N/A
Vanguard Extended Market Index Fund 71287 31 July, 2020 N/A
Fidelity Extended Market Index Fund 26300 31 July, 2020 N/A
Calamos Timpani Small Cap Growth Fund 15563 31 July, 2020 0.17
TIAA-CREF Small Cap Blend Index Fund 11267 30 June, 2020 N/A
Wasatch Ultra Growth Fund 501312 30 June, 2020 0.43
Victory RS Science and Technology Fund 81012 30 June, 2020 0.32
USAA Science & Technology Fund 287315 30 June, 2020 0.23
Wasatch Micro Cap Fund 114244 30 June, 2020 0.21
Fidelity Small Cap Index Fund 20251 30 April, 2020 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
XGN 16 June, 2022 0001782815 9000 0001274737 Stokes Frank A 4 9000 Stock Option(right to buy) View
XGN 16 June, 2022 0001616007 9000 0001274737 Birk Brian A 4 9000 Stock Option(right to buy) View
XGN 16 June, 2022 0001774825 9000 0001274737 Hooker Ana A 4 9000 Stock Option(right to buy) View
XGN 16 June, 2022 0001230641 9000 0001274737 TULLIS JAMES L L A 4 9000 Stock Option(right to buy) View
XGN 16 June, 2022 0001302605 9000 0001274737 Nova Tina Susan A 4 9000 Stock Option(right to buy) View
XGN 16 June, 2022 0001614597 9000 0001274737 PALLARES EBETUEL A 4 9000 Stock Option(right to buy) View
XGN 16 June, 2022 0001652822 9000 0001274737 Johnson Wendy S. A 4 9000 Stock Option(right to buy) View
XGN 1 March, 2022 0001492734 120678 0001274737 Rocca Fortunato R. D 4 4322 Common Stock View
XGN 1 March, 2022 0001788393 97759 0001274737 Adawi Kamal D 4 3241 Common Stock View
XGN 1 March, 2022 0001852986 99693 0001274737 Hazeltine Mark D 4 3241 Common Stock View
XGN 1 March, 2022 0001807743 84259 0001274737 Zack Debra D 4 3241 Common Stock View
XGN 4 February, 2022 0001492734 125000 0001274737 Rocca Fortunato R. A 4 75000 Common Stock View
XGN 4 February, 2022 0001788393 101000 0001274737 Adawi Kamal A 4 63500 Common Stock View
XGN 4 February, 2022 0001852986 102934 0001274737 Hazeltine Mark A 4 63500 Common Stock View
XGN 4 February, 2022 0001807743 87500 0001274737 Zack Debra A 4 50000 Common Stock View
XGN 3 September, 2021 0001652822 1000 0001274737 Johnson Wendy S. A 4 1000 Common Stock View
XGN 5 August, 2021 0001230641 1515672 0001274737 TULLIS JAMES L L D 4 6800 Common Stock View
XGN 4 August, 2021 0001230641 1522472 0001274737 TULLIS JAMES L L D 4 2100 Common Stock View
XGN 3 August, 2021 0001230641 1524572 0001274737 TULLIS JAMES L L D 4 4300 Common Stock View
XGN 2 August, 2021 0001230641 1528872 0001274737 TULLIS JAMES L L D 4 1800 Common Stock View
XGN 29 July, 2021 0001774825 15000 0001274737 Hooker Ana A 4 15000 Stock Option(right to buy) View
XGN 29 June, 2021 0001230641 1530672 0001274737 TULLIS JAMES L L D 4 5379 Common Stock View
XGN 28 June, 2021 0001230641 1536051 0001274737 TULLIS JAMES L L D 4 10858 Common Stock View
XGN 25 June, 2021 0001230641 1546909 0001274737 TULLIS JAMES L L D 4 8763 Common Stock View
XGN 17 June, 2021 0001652822 9000 0001274737 Johnson Wendy S. A 4 9000 Stock Option(right to buy) View
XGN 17 June, 2021 0001289625 9000 0001274737 Robertson Bruce C A 4 9000 Stock Option(right to buy) View
XGN 17 June, 2021 0001302605 9000 0001274737 Nova Tina Susan A 4 9000 Stock Option(right to buy) View
XGN 17 June, 2021 0001616007 9000 0001274737 Birk Brian A 4 9000 Stock Option(right to buy) View
XGN 17 June, 2021 0001230641 9000 0001274737 TULLIS JAMES L L A 4 9000 Stock Option(right to buy) View
XGN 17 June, 2021 0001614597 9000 0001274737 PALLARES EBETUEL A 4 9000 Stock Option(right to buy) View
XGN 17 June, 2021 0001782815 15000 0001274737 Stokes Frank A 4 15000 Stock Option(right to buy) View
XGN 17 May, 2021 0001852986 1061 0001274737 Hazeltine Mark D 4 1934 Stock Option(right to buy) View
XGN 17 May, 2021 0001852986 39434 0001274737 Hazeltine Mark A 4 1934 Common Stock View
XGN 23 February, 2021 0001788393 37500 0001274737 Adawi Kamal A 4 37500 Common Stock View
XGN 23 February, 2021 0001788393 12500 0001274737 Adawi Kamal A 4 12500 Stock Option(right to buy) View
XGN 23 February, 2021 0001492734 50000 0001274737 Rocca Fortunato R. A 4 50000 Common Stock View
XGN 23 February, 2021 0001492734 40000 0001274737 Rocca Fortunato R. A 4 40000 Stock Option(right to buy) View
XGN 23 February, 2021 0001807743 12500 0001274737 Zack Debra A 4 12500 Stock Option(right to buy) View
XGN 23 February, 2021 0001807743 37500 0001274737 Zack Debra A 4 37500 Common Stock View
XGN 5 February, 2021 0001230641 21348 0001274737 TULLIS JAMES L L D 4 3000 Common Stock View
XGN 25 January, 2021 0001788338 1261324 0001274737 Hunt Holdings Limited Partnership D 4 28021 Common Stock View
XGN 22 January, 2021 0001788338 1289345 0001274737 Hunt Holdings Limited Partnership D 4 23646 Common Stock View
XGN 21 January, 2021 0001788338 1312991 0001274737 Hunt Holdings Limited Partnership D 4 50000 Common Stock View
XGN 20 January, 2021 0001788338 1362991 0001274737 Hunt Holdings Limited Partnership D 4 30000 Common Stock View
XGN 19 January, 2021 0001788338 1392991 0001274737 Hunt Holdings Limited Partnership D 4 30000 Common Stock View
XGN 19 January, 2021 0001230641 24348 0001274737 TULLIS JAMES L L D 4 257 Common Stock View
XGN 15 January, 2021 0001230641 24605 0001274737 TULLIS JAMES L L D 4 1014 Common Stock View
XGN 13 January, 2021 0001230641 29619 0001274737 TULLIS JAMES L L D 4 1729 Common Stock View
XGN 13 January, 2021 0001230641 25619 0001274737 TULLIS JAMES L L D 4 4000 Common Stock View
XGN 12 January, 2021 0001788338 1422991 0001274737 Hunt Holdings Limited Partnership D 4 15000 Common Stock View
XGN 11 January, 2021 0001788338 1437991 0001274737 Hunt Holdings Limited Partnership D 4 7394 Common Stock View
XGN 8 January, 2021 0001788338 1445385 0001274737 Hunt Holdings Limited Partnership D 4 15186 Common Stock View
XGN 7 January, 2021 0001788338 1460571 0001274737 Hunt Holdings Limited Partnership D 4 10000 Common Stock View
XGN 15 December, 2020 0001788331 2308958 0001274737 NMSIC Co-Investment Fund, L.P. D 4 125000 Common Stock View
XGN 15 December, 2020 0001230641 1555672 0001274737 TULLIS JAMES L L D 4 12000 Common Stock View
XGN 11 December, 2020 0001230641 1567672 0001274737 TULLIS JAMES L L D 4 7500 Common Stock View
XGN 10 December, 2020 0001230641 1575172 0001274737 TULLIS JAMES L L D 4 10000 Common Stock View
XGN 11 November, 2020 0001788338 1470571 0001274737 Hunt Holdings Limited Partnership D 4 150 Common Stock View
XGN 10 November, 2020 0001788338 1470721 0001274737 Hunt Holdings Limited Partnership D 4 9045 Common Stock View
XGN 9 November, 2020 0001230641 31348 0001274737 TULLIS JAMES L L D 4 882 Common Stock View
XGN 9 November, 2020 0001788338 1479766 0001274737 Hunt Holdings Limited Partnership D 4 6752 Common Stock View
XGN 19 October, 2020 0001230641 32127 0001274737 TULLIS JAMES L L D 4 198 Common Stock View
XGN 16 October, 2020 0001230641 32325 0001274737 TULLIS JAMES L L D 4 2104 Common Stock View
XGN 15 October, 2020 0001230641 34429 0001274737 TULLIS JAMES L L D 4 4316 Common Stock View
XGN 1 October, 2020 0001652822 15000 0001274737 Johnson Wendy S. A 4 15000 Stock Option(right to buy) View
XGN 11 September, 2020 0001230641 1585275 0001274737 TULLIS JAMES L L D 4 15000 Common Stock View
XGN 1 September, 2020 0001788331 2433958 0001274737 NMSIC Co-Investment Fund, L.P. D 4 126404 Common Stock View
XGN 18 August, 2020 0001230641 1600275 0001274737 TULLIS JAMES L L D 4 2082 Common Stock View
XGN 14 August, 2020 0001230641 1602357 0001274737 TULLIS JAMES L L D 4 11507 Common Stock View
XGN 14 August, 2020 0001230641 38745 0001274737 TULLIS JAMES L L D 4 1398 Common Stock View
XGN 18 June, 2020 0001616007 9000 0001274737 Birk Brian A 4 9000 Stock Option(right to buy) View
XGN 18 June, 2020 0001614597 9000 0001274737 PALLARES EBETUEL A 4 9000 Stock Option(right to buy) View
XGN 18 June, 2020 0001788356 9000 0001274737 Burrell Chet A 4 9000 Stock Option(right to buy) View
XGN 18 June, 2020 0001689757 9000 0001274737 Elliott Jeffrey Thomas A 4 9000 Stock Option(right to buy) View
XGN 18 June, 2020 0001230641 9000 0001274737 TULLIS JAMES L L A 4 9000 Stock Option(right to buy) View
XGN 18 June, 2020 0001289625 9000 0001274737 Robertson Bruce C A 4 9000 Stock Option(right to buy) View
XGN 18 June, 2020 0001302605 9000 0001274737 Nova Tina Susan A 4 9000 Stock Option(right to buy) View
XGN 9 June, 2020 0001230641 40143 0001274737 TULLIS JAMES L L D 4 578 Common Stock View
XGN 9 June, 2020 0001230641 1613864 0001274737 TULLIS JAMES L L D 4 4782 Common Stock View
XGN 9 June, 2020 0001230641 1618646 0001274737 TULLIS JAMES L L D 4 1522 Common Stock View
XGN 28 May, 2020 0001230641 1620168 0001274737 TULLIS JAMES L L D 4 2240 Common Stock View
XGN 28 May, 2020 0001230641 40721 0001274737 TULLIS JAMES L L D 4 848 Common Stock View
XGN 27 May, 2020 0001230641 1622408 0001274737 TULLIS JAMES L L D 4 1595 Common Stock View
XGN 27 May, 2020 0001230641 41569 0001274737 TULLIS JAMES L L D 4 605 Common Stock View
XGN 20 May, 2020 0001230641 1624003 0001274737 TULLIS JAMES L L D 4 1162 Common Stock View
XGN 20 May, 2020 0001230641 42174 0001274737 TULLIS JAMES L L A 4 582 Common Stock View
XGN 13 April, 2020 0001788338 1486518 0001274737 Hunt Holdings Limited Partnership A 4 7703 Common Stock View
XGN 13 April, 2020 0001614597 0 0001274737 PALLARES EBETUEL D 4 144033 Common Stock View
XGN 13 April, 2020 0001614597 1185 0001274737 PALLARES EBETUEL A 4 1185 Common Stock View
XGN 24 March, 2020 0001807743 100000 0001274737 Zack Debra A 4 100000 Stock Option (Right to Buy) View
XGN 20 March, 2020 0001230641 1625165 0001274737 TULLIS JAMES L L D 4 164420 Common Stock View
XGN 20 March, 2020 0001144359 1625165 0001274737 TULLIS DICKERSON CAPITAL FOCUS III, L.P. D 4 164420 Common Stock View
XGN 11 March, 2020 0001614597 144033 0001274737 PALLARES EBETUEL D 4 214 Common Stock View
XGN 11 March, 2020 0001614597 0 0001274737 PALLARES EBETUEL D 4 22427 Warrants View
XGN 11 March, 2020 0001614597 144247 0001274737 PALLARES EBETUEL A 4 2265 Common Stock View
XGN 11 March, 2020 0001614597 144094 0001274737 PALLARES EBETUEL A 4 22427 Common Stock View
XGN 11 March, 2020 0001614597 141982 0001274737 PALLARES EBETUEL D 4 2112 Common Stock View
XGN 9 January, 2020 0001492734 155000 0001274737 Rocca Fortunato R. A 4 155000 Stock Option(right to buy) View
XGN 9 January, 2020 0001788393 52500 0001274737 Adawi Kamal A 4 52500 Stock Option(right to buy) View
XGN 23 September, 2019 0001614597 121667 0001274737 PALLARES EBETUEL A 4 120609 Common Stock View
SymbolDatePeriodDownload XLSX File
XGN 2021 FY Download XLSX File
XGN 2020 FY Download XLSX File
XGN 2019 FY Download XLSX File
XGN 2022 Q2 Download XLSX File
XGN 2022 Q1 Download XLSX File
XGN 2021 Q1 Download XLSX File
XGN 2021 Q2 Download XLSX File
XGN 2021 Q3 Download XLSX File
XGN 2021 Q4 Download XLSX File
XGN 2020 Q1 Download XLSX File
XGN 2020 Q2 Download XLSX File
XGN 2020 Q3 Download XLSX File
XGN 2020 Q4 Download XLSX File
XGN 2019 Q3 Download XLSX File
XGN 2019 Q4 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
4 August, 2022 XGN -0.78 -0.78 amc 8962000 12040000
11 May, 2022 XGN -0.6 -0.6 amc 10394000 0
22 March, 2022 XGN -0.42 -0.42 amc -12334000 11780000
10 November, 2021 XGN -0.42 -0.42 amc 12251000 12535906
9 August, 2021 XGN -0.38 -0.38 amc 12772000 12772000
11 May, 2021 XGN -0.48 -0.48 amc 10587000 10361744
16 March, 2021 XGN -0.27 -0.27 amc 12668000 0
28 July, 2020 XGN -0.27 -0.27 bmo 8948000 25186962.962963
11 May, 2020 XGN -0.44 -0.44 amc 9584000 10673090.909091
25 March, 2020 XGN -0.27 -0.27 amc 10214000 13996962.962963
12 November, 2019 XGN -2.3 -2.3 amc 10439000 10873958
20 September, 2019 XGN bmo 10474000 0

Company Profile

Company Name Exagen Inc.
Symbol XGN
Currency USD
Price 5.272
Exchange Name NASDAQ Global Market (NASDAQ)
Industry Diagnostics & Research
CEO Mr. Fortunato Rocca
Sector Healthcare
Country US
Full Time Employees 219
Phone 18884521522
Address 1261 Liberty Way Ste C
City Vista
State CALIFORNIA
Zip 92081
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody and associated vasculitis; AVISE Anti-CarP test, which identifies RA patients with severe disease; and AVISE PC4d to measure platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.